UiPath Stock Forecast, Price & News

UiPath (NASDAQ:PATH) Frequently Asked Questions

Is UiPath a buy right now?

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" UiPath stock.
View analyst ratings for UiPath or view top-rated stocks.

How has UiPath's stock been impacted by COVID-19 (Coronavirus)?

UiPath's stock was trading at $18.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PATH shares have increased by 92.9% and is now trading at $34.73.
View which stocks have been most impacted by COVID-19.

How were UiPath's earnings last quarter?

UiPath Inc. (NASDAQ:PATH) issued its quarterly earnings data on Wednesday, December, 8th. The healthcare company reported ($0.17) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.13. The healthcare company had revenue of $220.82 million for the quarter, compared to analysts' expectations of $209.23 million. The firm's revenue for the quarter was up 49.9% compared to the same quarter last year.
View UiPath's earnings history.

What guidance has UiPath issued on next quarter's earnings?

UiPath updated its fourth quarter 2022 earnings guidance on Wednesday, December, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $281 million-$283 million, compared to the consensus revenue estimate of $281.12 million.

What price target have analysts set for PATH?

21 equities research analysts have issued 12-month target prices for UiPath's shares. Their forecasts range from $40.00 to $85.00. On average, they expect UiPath's share price to reach $66.71 in the next year. This suggests a possible upside of 92.1% from the stock's current price.
View analysts' price targets for UiPath or view top-rated stocks among Wall Street analysts.

What are Wall Street analysts saying about UiPath stock?

Here are some recent quotes from research analysts about UiPath stock:

• 1. According to Zacks Investment Research, "UiPath Inc. offers an end-to-end platform for automation, combining Robotic Process Automation solution for digital business operations. UiPath Inc. is based in New York, United States. " (12/14/2021)
• 2. The analyst says his price target cut reflects his updated discount cash flow model, but he also recommends that investors take advantage of the broad weakness that has impacted software as an attractive buying opportunity to buy UiPath for its long-term compounding growth story. Tillman further points to the company's record net new ARR, "constructive" Q4 outlook, and a variety of new innovations in the pipeline such as automation bots for Mac users, multi-cloud multi-platform capabilities, automation cloud traction, and task/process mining." (12/9/2021)
• 3. The analyst notes UiPath delivered another "solid" beat across top-line metrics for Q3, including a quarterly record for net new ARR and total revenue growth of +50%. While Q3 was strong, the full-year ARR guide increased by $22M, implying a modest $2M raise post the $20M Q3 beat, Turrin adds. With Q3 results coming in clean, he expects investor conversation will focus in on what's ahead for new business activity into a seasonally strong Q4 and the potential for pent-up automation demand in a tight labor market heading into fiscal 2023. While UiPath continues to blaze a trail toward broad-based RPA adoption, current valuation levels and a rapidly evolving market backdrop leave the analyst more balanced on shares. " (12/9/2021)

Who are UiPath's key executives?

UiPath's management team includes the following people:

• Mr. Daniel Solomon Dines, Co-Founder, CEO, & Chairman (Age 49)
• Mr. Marius Tirca, Co-Founder & CTO
• Mr. Ashim Gupta, Chief Financial Officer (Age 42) (LinkedIn Profile)
• Mr. Brad C. Brubaker, Gen. Counsel, Chief Legal Officer & Sec. (Age 57) (LinkedIn Profile)
• Mr. Robert B. Patrick, Chief Marketing Officer (Age 49)
• Mr. Christopher Townsend, VP of Federal Sales
• Mr. Vijay Khanna, Chief Corp. Devel. Officer
• Ms. Bettina H. Koblick, Chief People Officer (Age 55)
• Mr. Vargha Moayed, Chief Strategy Officer
• Mr. Chris Klayko, Sr. VP & MD of Americas

Who are some of UiPath's key competitors?

Some companies that are related to UiPath include Dassault Systèmes (DASTY), NetEase (NTES), Activision Blizzard (ATVI), Square (SQ), Autodesk (ADSK), VMware (VMW), Synopsys (SNPS), Cadence Design Systems (CDNS), Electronic Arts (EA), Datadog (DDOG), Atlassian (TEAM), CrowdStrike (CRWD), Roblox (RBLX), Twilio (TWLO) and Veeva Systems (VEEV).
View all of PATH's competitors.

What other stocks do shareholders of UiPath own?

Based on aggregate information from My MarketBeat watchlists, some companies that other UiPath investors own include Amyris (AMRS), Alpha Natural Resources (ANRZQ), Aralez Pharmaceuticals (ARLZ), Arena Pharmaceuticals (ARNA), BlackBerry (BB), Ballard Power Systems (BLDP), Central European Media Enterprises (CETV), Canadian Solar (CSIQ), FuelCell Energy (FCEL) and Glu Mobile (GLUU).

When did UiPath IPO?

(PATH) raised $990 million in an IPO on Wednesday, April 21st 2021. The company issued 21,300,000 shares at $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities acted as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.

What is UiPath's stock symbol?

UiPath trades on the NASDAQ under the ticker symbol "PATH."

Who are UiPath's major shareholders?

UiPath's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vista Wealth Management Group LLC (0.04%), Royal London Asset Management Ltd. (0.01%), Cutler Group LP (0.00%), Parallel Advisors LLC (0.00%), Kestra Private Wealth Services LLC (0.00%) and Archford Capital Strategies LLC (0.00%). Company insiders that own UiPath stock include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert and Thomas Neergaard Hansen.
View institutional ownership trends for UiPath.

Which institutional investors are selling UiPath stock?

PATH stock was sold by a variety of institutional investors in the last quarter, including Vista Wealth Management Group LLC, and AdvisorNet Financial Inc. Company insiders that have sold UiPath company stock in the last year include Ashim Gupta, Brad Brubaker, Daniel Dines, East Fund 2013 Sca Sic Digital, Hitesh Ramani, Kimberly Hammonds, Laela Sturdy, Philippe Botteri, Rich Wong, Ted Kummert, and Thomas Neergaard Hansen.
View insider buying and selling activity for UiPath or view top insider-selling stocks.

Which institutional investors are buying UiPath stock?

PATH stock was acquired by a variety of institutional investors in the last quarter, including Royal London Asset Management Ltd., Cutler Group LP, Parallel Advisors LLC, Kestra Private Wealth Services LLC, Lattice Capital Management LLC, U.S. Capital Wealth Advisors LLC, New England Research & Management Inc., and IFP Advisors Inc.
View insider buying and selling activity for UiPath or or view top insider-buying stocks.

How do I buy shares of UiPath?

Shares of PATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is UiPath's stock price today?

One share of PATH stock can currently be purchased for approximately $34.73.

How much money does UiPath make?

UiPath has a market capitalization of $18.24 billion.

How many employees does UiPath have?

UiPath employs 2,863 workers across the globe.

Does UiPath have any subsidiaries?

The following companies are subsidiares of UiPath: Magna View BV, Process Gold International BV, ProcessGold, StepShot, UiPath AB, UiPath Australia Pty Ltd, UiPath Canada, UiPath China - Shanghai, UiPath France SAS, UiPath GMBH, UiPath Hong Kong, UiPath KK, UiPath Limited, UiPath Ltd. (India), UiPath Ltd. (SG), UiPath Ltd. (UK), UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath SRL, UiPath South Korea, and UiPath Switzerland GmbH.

When was UiPath founded?

UiPath was founded in 2005.

What is UiPath's official website?

The official website for UiPath is www.nupathe.com.

Where are UiPath's headquarters?

UiPath is headquartered at 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States.

How can I contact UiPath?

UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company can be reached via email at [email protected].